157 related articles for article (PubMed ID: 17459323)
1. Reaction mechanisms of 15-hydroperoxyeicosatetraenoic acid catalyzed by human prostacyclin and thromboxane synthases.
Yeh HC; Tsai AL; Wang LH
Arch Biochem Biophys; 2007 May; 461(2):159-68. PubMed ID: 17459323
[TBL] [Abstract][Full Text] [Related]
2. The N-terminal membrane anchor domain of the membrane-bound prostacyclin synthase involved in the substrate presentation of the coupling reaction with cyclooxygenase.
Ruan KH; Deng H; Wu J; So SP
Arch Biochem Biophys; 2005 Mar; 435(2):372-81. PubMed ID: 15708381
[TBL] [Abstract][Full Text] [Related]
3. Characterization of heme environment and mechanism of peroxide bond cleavage in human prostacyclin synthase.
Yeh HC; Hsu PY; Wang JS; Tsai AL; Wang LH
Biochim Biophys Acta; 2005 Dec; 1738(1-3):121-32. PubMed ID: 16406803
[TBL] [Abstract][Full Text] [Related]
4. Expression of thromboxane synthase, prostacyclin synthase and thromboxane receptor in atherosclerotic lesions: correlation with plaque composition.
Cyrus T; Ding T; Praticò D
Atherosclerosis; 2010 Feb; 208(2):376-81. PubMed ID: 19735918
[TBL] [Abstract][Full Text] [Related]
5. Increased 15-HPETE production decreases prostacyclin synthase activity during oxidant stress in aortic endothelial cells.
Weaver JA; Maddox JF; Cao YZ; Mullarky IK; Sordillo LM
Free Radic Biol Med; 2001 Feb; 30(3):299-308. PubMed ID: 11165876
[TBL] [Abstract][Full Text] [Related]
6. Altered prostanoid metabolism contributes to impaired angiogenesis in persistent pulmonary hypertension in a fetal lamb model.
Mahajan CN; Afolayan AJ; Eis A; Teng RJ; Konduri GG
Pediatr Res; 2015 Mar; 77(3):455-62. PubMed ID: 25521916
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the secondary structure and membrane interaction of the putative membrane anchor domains of prostaglandin I2 synthase and cytochrome P450 2C1.
Lin Y; Wu KK; Ruan KH
Arch Biochem Biophys; 1998 Apr; 352(1):78-84. PubMed ID: 9521818
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of hydroperoxide reduction by mangano-prostaglandin endoperoxide synthase.
Landino LM; Marnett LJ
Biochemistry; 1996 Feb; 35(8):2637-43. PubMed ID: 8611568
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of recombinant human prostacyclin synthase.
Wada M; Yokoyama C; Hatae T; Shimonishi M; Nakamura M; Imai Y; Ullrich V; Tanabe T
J Biochem; 2004 Apr; 135(4):455-63. PubMed ID: 15115769
[TBL] [Abstract][Full Text] [Related]
10. Double-label expression studies of prostacyclin synthase, thromboxane synthase and COX isoforms in normal aortic endothelium.
Kawka DW; Ouellet M; Hétu PO; Singer II; Riendeau D
Biochim Biophys Acta; 2007 Jan; 1771(1):45-54. PubMed ID: 17189713
[TBL] [Abstract][Full Text] [Related]
11. Rabbit aorta converts 15-HPETE to trihydroxyeicosatrienoic acids: potential role of cytochrome P450.
Pfister SL; Spitzbarth N; Zeldin DC; Lafite P; Mansuy D; Campbell WB
Arch Biochem Biophys; 2003 Dec; 420(1):142-52. PubMed ID: 14622984
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450-dependent transformations of 15R- and 15S-hydroperoxyeicosatetraenoic acids: stereoselective formation of epoxy alcohol products.
Chang MS; Boeglin WE; Guengerich FP; Brash AR
Biochemistry; 1996 Jan; 35(2):464-71. PubMed ID: 8555216
[TBL] [Abstract][Full Text] [Related]
13. Homology Modeling and Molecular Dynamics Simulation Combined with X-ray Solution Scattering Defining Protein Structures of Thromboxane and Prostacyclin Synthases.
Yang HC; Yang CH; Huang MY; Lu JF; Wang JS; Yeh YQ; Jeng US
J Phys Chem B; 2017 Dec; 121(50):11229-11240. PubMed ID: 29168638
[TBL] [Abstract][Full Text] [Related]
14. Qualitative and quantitative analysis of lipoxygenase products in bovine corneal epithelium by liquid chromatography-mass spectrometry with an ion trap.
Liminga M; Oliw E
Lipids; 2000 Feb; 35(2):225-32. PubMed ID: 10757554
[TBL] [Abstract][Full Text] [Related]
15. Suggested mechanism for the formation of 15-hydroxyeicosatrienoic acid by rat epidermal microsomes.
Van Wauwe J; Coene MC; Van Nyen G; Cools W; Le Jeune L; Lauwers W
Eicosanoids; 1992; 5(3-4):141-6. PubMed ID: 1292524
[TBL] [Abstract][Full Text] [Related]
16. Role of prostacyclin synthase in carcinogenesis.
Sasaki Y; Ochiai T; Takamura M; Kondo Y; Yokoyama C; Hara S
Prostaglandins Other Lipid Mediat; 2017 Nov; 133():49-52. PubMed ID: 28506876
[TBL] [Abstract][Full Text] [Related]
17. An active triple-catalytic hybrid enzyme engineered by linking cyclo-oxygenase isoform-1 to prostacyclin synthase that can constantly biosynthesize prostacyclin, the vascular protector.
Ruan KH; So SP; Cervantes V; Wu H; Wijaya C; Jentzen RR
FEBS J; 2008 Dec; 275(23):5820-9. PubMed ID: 19021758
[TBL] [Abstract][Full Text] [Related]
18. Depletion of iNOS-derived nitric oxide by prostaglandin H synthase-2 in inflammation-activated J774.2 macrophages through lipohydroperoxidase turnover.
Clark SR; Anning PB; Coffey MJ; Roberts AG; Marnett LJ; O'Donnell VB
Biochem J; 2005 Feb; 385(Pt 3):815-21. PubMed ID: 15461587
[TBL] [Abstract][Full Text] [Related]
19. Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH and selenocystine strongly stimulates the reaction via catalytically generated selenols.
Björnstedt M; Hamberg M; Kumar S; Xue J; Holmgren A
J Biol Chem; 1995 May; 270(20):11761-4. PubMed ID: 7744824
[TBL] [Abstract][Full Text] [Related]
20. Substrate binding is the rate-limiting step in thromboxane synthase catalysis.
Wang LH; Tsai AL; Hsu PY
J Biol Chem; 2001 May; 276(18):14737-43. PubMed ID: 11297515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
